Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

Concordare Trials

Concordare Trials

Concordare Trials converts clinical study protocols into a digital model that generates source documents, EDC builds, and CTMS configurations.

HQ

New York, NY, US

Founded

Concordare Trials builds infrastructure that extracts trial information from study design documents into a structured Clinical Trial Protocol Model (CTPM) using an AI-powered conversion engine called Apta. From that single source of truth the platform automatically generates source documents, electronic data capture builds, CTMS configurations, and billing grids.

The platform serves clinical trial sites, CROs, and sponsors across therapeutic areas, with every generated output reviewed and validated by a human team before release. Concordare Trials positions its model as a reusable foundation intended to shorten study startup times and reduce manual data entry across a trial's operational systems.

Concordare Trials - Products & Services

Concordare Suite
Concordare Suite converts clinical trial protocol documents into a digital model that generates study builds.
Competing Products

Concordare Trials - Similar Companies

ClinCapture

clincapture.com

OpenClinica

openclinica.com

Biogenesis Trials

mybiogenesis.com

Truco

truco.ai

Clario

clario.com

Trial Library

triallibrary.com

Medable

medable.com

Harbor

runharbor.com

ProofPilot

proofpilot.com

Procode

tryprocode.com

Clinical Research IO

Hippocratic AI

hippocraticai.com

Ascertain

ascertain.com

Concord

concordnow.com

QMENTA

qmenta.com

Concordare Trials - Quick Facts

Who are Concordare Trials' competitors?

Companies similar to Concordare Trials include ClinCapture, OpenClinica, Biogenesis Trials and Truco.

When was Concordare Trials founded?

Concordare Trials was founded in 2023.

Where is Concordare Trials' headquarters located?

Concordare Trials' headquarters is located in New York, NY, US.

Concordare Trials - Classification

Industry: Healthcare
Medical Software
Technology: AI Machine Learning

Model: Software Platform
Customer: Healthcare Providers

Tags: Digital Health